RESPONSE: Re: A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma

Saved in:
Bibliographic Details
Published inJNCI : Journal of the National Cancer Institute Vol. 95; no. 4; pp. 333 - 334
Main Authors Saad, Fred, Gleason, Donald M., Murray, Robin, Goas, J. Allen, Chen, Bee
Format Journal Article
LanguageEnglish
Published Oxford University Press 19.02.2003
Online AccessGet full text

Cover

More Information
Bibliography:istex:4855F755E581C0688D515FAD73F3EDE775736A7C
ark:/67375/HXZ-KZF9FQDW-F
local:0950333
Correspondence to: Fred Saad, M.D., Uro-Oncology Clinic, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, 1560 Rue Sherbrooke East, Montréal, Quebec, Canada H2L 4M1 (e-mail: fred.saad@ssss.gouv.qc.ca).
PII:1460-2105
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/95.4.333